RETRACTED: Ginsenoside Rg3 inhibits growth and epithelial-mesenchymal transition of human oral squamous carcinoma cells by down-regulating miR-221

Zhou Cheng, Dayuan Xing

Open source

DOI
10.1016/j.ejphar.2019.03.040
Published
2019-06
Container
European Journal of Pharmacology
Publisher
Elsevier BV
Open access
unknown

Credibility signals

serious concern Score 11/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1016/j.ejphar.2019.03.040,
  title = {RETRACTED: Ginsenoside Rg3 inhibits growth and epithelial-mesenchymal transition of human oral squamous carcinoma cells by down-regulating miR-221},
  author = {Zhou Cheng and Dayuan Xing},
  year = {2019},
  journal = {European Journal of Pharmacology},
  doi = {10.1016/j.ejphar.2019.03.040},
  url = {https://doi.org/10.1016/j.ejphar.2019.03.040}
}

RIS

TY  - JOUR
TI  - RETRACTED: Ginsenoside Rg3 inhibits growth and epithelial-mesenchymal transition of human oral squamous carcinoma cells by down-regulating miR-221
AU  - Zhou Cheng
AU  - Dayuan Xing
PY  - 2019
JO  - European Journal of Pharmacology
DO  - 10.1016/j.ejphar.2019.03.040
UR  - https://doi.org/10.1016/j.ejphar.2019.03.040
ER  - 

APA

Cheng, Z., & Xing, D. (2019). RETRACTED: Ginsenoside Rg3 inhibits growth and epithelial-mesenchymal transition of human oral squamous carcinoma cells by down-regulating miR-221. European Journal of Pharmacology. https://doi.org/10.1016/j.ejphar.2019.03.040

Source records